Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
4.270
-0.050 (-1.16%)
At close: Jul 27, 2026, 4:00 PM EDT
4.270
0.00 (0.00%)
Pre-market: Jul 28, 2026, 9:13 AM EDT
Clover Health Investments Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Clover Health Investments stock has a consensus rating of "Buy" and an average price target of $4.58. The average 1-year stock price forecast is 7.26% higher than the current stock price, while the lowest is $3.50 (-18.03%) and the highest is $5.50 (+28.81%).
Price Target: $4.58 (+7.26%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Clover Health Investments stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $4.2 → $5.5 | Buy | Maintains | $4.2 → $5.5 | +28.81% | Jul 21, 2026 |
| UBS | UBS | Hold Maintains $2.75 → $4.75 | Hold | Maintains | $2.75 → $4.75 | +11.24% | Jun 11, 2026 |
Financial Forecast
Revenue This Year
2.91B
from 1.92B
Increased by 51.30%
Revenue Next Year
3.40B
from 2.91B
Increased by 16.90%
EPS This Year
0.09
from 0.04
Increased by 130.77%
EPS Next Year
0.10
from 0.09
Increased by 11.11%
EPS and Forward PE are based on non-GAAP adjusted numbers.